NEW YORK (GenomeWeb News) – Warnex has signed up Biron Laboratoire medical, a diagnostic and medical services provider in Quebec, to distribute its test for influenza A H1N1, Warnex said yesterday.

Warnex said Biron, which operates more than 100 sites throughout Quebec, will promote and distribute the test and will specifically target industrial companies as customers.

The Warnex test uses RT-PCR to detect the A H1N1 strain in as little as eight hours, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.